TKG Advisors LLC Makes New $2.16 Million Investment in Colgate-Palmolive (NYSE:CL)

TKG Advisors LLC acquired a new stake in Colgate-Palmolive (NYSE:CLFree Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 20,768 shares of the company’s stock, valued at approximately $2,156,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Norden Group LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $532,000. Choreo LLC grew its stake in Colgate-Palmolive by 6.4% during the 1st quarter. Choreo LLC now owns 7,476 shares of the company’s stock valued at $673,000 after purchasing an additional 452 shares during the last quarter. Daiwa Securities Group Inc. increased its holdings in shares of Colgate-Palmolive by 8.7% in the first quarter. Daiwa Securities Group Inc. now owns 84,231 shares of the company’s stock valued at $7,585,000 after purchasing an additional 6,742 shares during the period. Mutual of America Capital Management LLC raised its stake in shares of Colgate-Palmolive by 15.8% in the first quarter. Mutual of America Capital Management LLC now owns 127,798 shares of the company’s stock worth $11,508,000 after purchasing an additional 17,457 shares during the last quarter. Finally, Financial Counselors Inc. lifted its holdings in shares of Colgate-Palmolive by 3.5% during the first quarter. Financial Counselors Inc. now owns 19,348 shares of the company’s stock worth $1,742,000 after purchasing an additional 646 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 in the last three months. 0.34% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CL. UBS Group raised their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. Evercore ISI lifted their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. Finally, Jefferies Financial Group cut Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $105.11.

Read Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

CL stock traded up $0.36 during mid-day trading on Monday, reaching $93.69. The company’s stock had a trading volume of 305,845 shares, compared to its average volume of 4,343,415. The stock has a market cap of $76.55 billion, a PE ratio of 26.74, a P/E/G ratio of 3.35 and a beta of 0.42. The company’s 50 day moving average is $102.26 and its two-hundred day moving average is $98.35. Colgate-Palmolive has a fifty-two week low of $74.67 and a fifty-two week high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.28 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.13%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.